Company news
Fennec Pharmaceuticals Inc. news in 2025
Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2025, newest first.
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
December 9, 2025
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
December 2, 2025
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
November 19, 2025
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
November 18, 2025
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
November 17, 2025
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada
November 13, 2025
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
November 13, 2025
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
November 13, 2025
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
August 14, 2025
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
August 11, 2025
Fennec Announces Results of Annual Meeting
June 3, 2025
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 8, 2025
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 10, 2025
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
March 6, 2025
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
February 6, 2025